Depocyt® With Sorafenib in Neoplastic Meningitis

NCT00964743 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Neoplastic Meningitis

Interventions

DRUG: DepoCyt
DRUG: Sorafenib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]